26 0

ZURICH (Reuters) - Novartis nudged up its operating profit guidance on Tuesday, as the Swiss drugmaker predicted healthcare systems would navigate a second COVID-19 wave better than the first and keep drug sales flowing. FILE PHOTO: The logo of Swiss drugmaker Novartis is pictured at the French company's headquarters in Rueil-Malmaison near Paris, France, April 22, 2020. REUTERS/Charles Platiau/File Photo. The company now expects 2020 operating income growth in a low-to-mid double-digit percentage range, compared with a low double-digit rate forecast previously. Sales are seen rising by a mid single-digit percentage, unchanged from previous guidance. Third-quarter core net income climbed 8... Full story

27 October